PRME (STOCKS)
Prime Medicine, Inc. Common Stock
$3.280000
-0.170000 (-4.93%)
Prev close: $3.450000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Allan Jacob Reine
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $598.39M
- Employees
- 214
- P/E (TTM)
- -2.25
- P/B (TTM)
- 3.84
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
7
Buy
5
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.32 | $-0.26 | -0.0619 | -23.98% |
|
Jun 2025 (Q2)
|
$-0.41 | $-0.37 | -0.0391 | -10.54% |
|
Mar 2025 (Q1)
|
$-0.40 | $-0.33 | -0.0735 | -22.51% |
|
Dec 2024 (Q4)
|
$-0.31 | $-0.40 | +0.0898 | +22.46% |
Financial Statements
| Revenues | $5.98M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $209.94M |
| Nonoperating Income/Loss | $6.63M |
| Operating Expenses | $209.94M |
| Research and Development | $160.03M |
| Other Operating Expenses | $49.91M |
| Operating Income/Loss | -$203.96M |
| Income/Loss From Continuing Operations After Tax | -$197.34M |
| Income/Loss From Continuing Operations Before Tax | -$101.07M |
| Net Income/Loss | -$197.34M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$197.34M |
| Net Income/Loss Available To Common Stockholders, Basic | -$197.34M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.44 |
| Diluted Earnings Per Share | -$1.44 |
| Basic Average Shares | 424,681,556 |
| Diluted Average Shares | 424,681,556 |
| Assets | $385.01M |
| Current Assets | $231.41M |
| Cash | $213.30M |
| Prepaid Expenses | $2.49M |
| Other Current Assets | $15.61M |
| Noncurrent Assets | $153.61M |
| Fixed Assets | $22.05M |
| Other Non-current Assets | $131.56M |
| Liabilities | $223.19M |
| Current Liabilities | $35.02M |
| Accounts Payable | $9.35M |
| Wages | $6.76M |
| Other Current Liabilities | $18.91M |
| Noncurrent Liabilities | $188.17M |
| Equity | $161.82M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $161.82M |
| Liabilities And Equity | $385.01M |
| Net Cash Flow From Operating Activities | -$109.06M |
| Net Cash Flow From Operating Activities, Continuing | -$109.06M |
| Net Cash Flow From Investing Activities | -$88.84M |
| Net Cash Flow From Investing Activities, Continuing | -$88.84M |
| Net Cash Flow From Financing Activities | $150.95M |
| Net Cash Flow From Financing Activities, Continuing | $150.95M |
| Net Cash Flow | -$46.95M |
| Net Cash Flow, Continuing | -$46.95M |
| Comprehensive Income/Loss | -$197.32M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$197.33M |
| Other Comprehensive Income/Loss | -$92.84M |